IGC Pharma
36 hedge funds and large institutions have $2.27M invested in IGC Pharma in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.1% more ownership
Funds ownership: 3.81% → 5.92% (+2.1%)
Holders
36
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$485K | |
| 2 | +$210K | |
| 3 | +$149K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$62.2K |
| 5 |
HF
HRT Financial
New York
|
+$25K |
Top Sellers
| 1 | -$13.9K | |
| 2 | -$4.08K | |
| 3 | -$878 | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$55 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$41 |
